Asymmetric dimethylarginine (ADMA) plays a crucial role in endothelial function and maybe a link for the known interaction of periodontitis and coronary heart disease (CHD). In this pilot study, we compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on salivary and serum ADMA levels.
Titolo: | Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk |
Autori interni: | IENTILE, RICCARDO (Penultimo) |
Data di pubblicazione: | 2020 |
Rivista: | |
Handle: | http://hdl.handle.net/20.500.11769/375154 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.